Post Thrombotic Syndrome Prevention Study

首次发布于 2017 年 2 月 1 日

Biomarkers in Post Thrombotic Syndrome

计划入组 235 人 · 首次发布于 2015 年 3 月 3 日

Treatment Trial for Post-Thrombotic Syndrome

计划入组 31 人 · 首次发布于 2008 年 3 月 12 日

GPVI inhibitors (thrombotic disorders)

Post-transfection F17(GlaxoSmithKline)

Post-transfection F19(GlaxoSmithKline)

ALPORT SYNDROME FOUNDATION

United States

US THROMBOTIC MICROANGIOPATHY ALLIANCE

United States

International Rett Syndrome Foundation

United States

NIH-Sponsored Trial Shows Stent Placement Significantly Reduces Post-Thrombotic Syndrome Severity

GORE VIABAHN FORTEGRA Venous Stent Achieves 83.4% Primary Patency in Deep Venous Obstruction Trial

FDA Approves First Venous Stent for Deep Venous Disease in IVC and Iliofemoral Veins